Schroder Investment Management Group
HRMY icon

Schroder Investment Management Group’s Harmony Biosciences HRMY Stock Holding History

Schroder Investment Management Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-72,678
Closed -$2.74M – 1223
2025
Q4 		$2.74M Buy
72,678
+16,532
+29% +$544K ﹤0.01% 840
2025
Q3 		$1.55M Sell
56,146
-4,418
-7% -$152K ﹤0.01% 971
2025
Q2 		$1.91M Sell
60,564
-119
-0.2% -$3.83K ﹤0.01% 917
2025
Q1 		$2.01M Buy
+60,683
New +$2.18M ﹤0.01% 902
2024
Q4 		– Sell
-29,579
Closed -$1.16M – 1218
2024
Q3 		$1.16M Hold
29,579
– – ﹤0.01% 1012
2024
Q2 		$892K Sell
29,579
-147,875
-83% -$4.45M ﹤0.01% 1048
2024
Q1 		$5.96M Sell
177,454
-50,046
-22% -$1.61M 0.01% 750
2023
Q4 		$7.35M Buy
+227,500
New +$6.35M 0.01% 690
2023
Q3 		– Sell
-106,527
Closed -$3.75M – 1217
2023
Q2 		$3.75M Sell
106,527
-151,861
-59% -$5.24M 0.01% 836
2023
Q1 		$8.44M Buy
258,388
+117,404
+83% +$5.35M 0.01% 665
2022
Q4 		$7.77M Buy
140,984
+74,422
+112% +$4.09M 0.01% 680
2022
Q3 		$2.95M Buy
+66,562
New +$3.25M ﹤0.01% 871
2022
Q1 		– Sell
-33,469
Closed -$1.43M – 1460
2021
Q4 		$1.43M Buy
+33,469
New +$1.33M ﹤0.01% 983

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Schroder Investment Management Group's HRMY Position: Q1 2026 in Review

Schroder Investment Management Group sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 72,678 shares — an estimated $2.74M sold.

Schroder Investment Management Group first reported a position in HRMY in Q4 2021 and held it in 13 quarters. The position peaked at $8.44M in Q1 2023. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Schroder Investment Management Group reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 72,678 Harmony Biosciences shares in Q1 2026, an estimated $2.74M.
  • Schroder Investment Management Group first reported a position in Harmony Biosciences in Q4 2021 and held it in 13 quarters.
  • Schroder Investment Management Group's Harmony Biosciences position peaked at $8.44M in Q1 2023.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.